YFP

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol

Created:	2021-02-25
Last modified:	2021-07-28

Find Related PDB Entry
5 entries where YFP is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	128
Chiral Atom Count	1
Bond Count	127
Aromatic Bond Count	0

2D diagram of YFP

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol
Synonyms	(19R,22R)-22,25,26-trihydroxy-16,22-dioxo-17,21,23-trioxa-22lambda~5~-phosphahexacosan-19-yl octadec-9-enoate
Systematic Name (OpenEye OEToolkits)	[(2~{R})-1-[2,3-bis(oxidanyl)propoxy-oxidanyl-phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] octadec-9-enoate
Formula	C₄₀ H₇₇ O₁₀ P
Molecular Weight	749.007
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(OC(COP(O)(=O)OCC(O)CO)COC(=O)CCCCCCCCCCCCCCC)CCCCCCC\C=C\CCCCCCCC
SMILES	CACTVS	3.385	CCCCCCCCCCCCCCCC(=O)OC[CH](CO[P](O)(=O)OCC(O)CO)OC(=O)CCCCCCCC=CCCCCCCCC
SMILES	OpenEye OEToolkits	2.0.7	CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCC=CCCCCCCCC
Canonical SMILES	CACTVS	3.385	CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P](O)(=O)OCC(O)CO)OC(=O)CCCCCCCC=CCCCCCCCC
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCC=CCCCCCCCC
InChI	InChI	1.03	InChI=1S/C40H77O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,37-38,41-42H,3-16,19-36H2,1-2H3,(H,45,46)/t37?,38-/m1/s1
InChIKey	InChI	1.03	PAZGBAOHGQRCBP-YWIOZPJLSA-N

Related Resource References

Resource Name	Reference
PubChem	155293303

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.